Elon Musk’s Neuralink Corp. is staking more territory in Austin. The company developing brain-computer interfaces is spending $8.2 million to expand its facilities in Del Valle and recruiting for a ...

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore blind ...

Tech billionaire’s brain implant start-up's leap into human trials sparks ethical concerns, casting a spotlight on the ...

Neuralink is launching a trial to see if patients can use its brain implant can control a robot arm. Elon Musk's company said the study was a step toward "not only digital freedom, but physical ...

Internal documents reveal that Neuralink expects to implant 20,000 people with its BCI chips by 2031.

Forbes contributors publish independent expert analyses and insights. I write about the big picture of artificial intelligence. We stand at the cusp of a massive technology paradigm shift that ...

Elon Musk's Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers. A July 2024 report by IDTechEx projects that the ...

(Reuters) -Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device enters clinical trials. "This funding helps us bring our ...

In an interview on Monday, the billionaire said his Neuralink brain-implant company is progressing in its development of ...

Neurotech startup Paradromics is gearing up to conduct human trials of its brain implant in the coming year, marking its entry into the competitive brain-computer interface (BCI) market where Elon ...

Synchron Inc. raised $200 million to advance its work building brain implants that doctors can insert through blood vessels, ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Neuralink has successfully implanted its brain chip in two human patients — and now it wants to hook ...